# Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood

> **NCT00150566** · PHASE3 · COMPLETED · sponsor: **Shire** · enrollment: 460 (—)

## Conditions studied

- Kidney Failure, Chronic

## Interventions

- **DRUG:** Lanthanum carbonate

## Key facts

- **NCT ID:** NCT00150566
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02-09
- **Primary completion:** 2005-10-08
- **Final completion:** 2005-10-08
- **Target enrollment:** 460 (—)
- **Last updated:** 2021-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00150566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00150566, "Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their Blood". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00150566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*